Amide-based inhibitors of p38a MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides
Optimization of a tri-substituted N-pyridyl amide led to the discovery of a new class of potent N-pyrimidyl amide based p38a MAP kinase inhibitors. Initial SAR studies led to the identification of 5-dihydrofuran as an optimal hydrophobic group. Additional side chain modifications resulted in the int...
Gespeichert in:
| Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2010-04, Vol.20 (8), p.2560-2563 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2563 |
|---|---|
| container_issue | 8 |
| container_start_page | 2560 |
| container_title | Bioorganic & medicinal chemistry letters |
| container_volume | 20 |
| creator | Tester, Richland Tan, Xuefei Luedtke, Gregory R Nashashibi, Imad Schinzel, Kurt Liang, Weiling Jung, Joon Dugar, Sundeep Liclican, Albert Tabora, Jocelyn Levy, Daniel E Do, Steven |
| description | Optimization of a tri-substituted N-pyridyl amide led to the discovery of a new class of potent N-pyrimidyl amide based p38a MAP kinase inhibitors. Initial SAR studies led to the identification of 5-dihydrofuran as an optimal hydrophobic group. Additional side chain modifications resulted in the introduction of hydrogen bond interactions. Through extensive SAR studies, analogs bearing free amino groups and alternatives to the parent (S)-a-methyl benzyl moiety were identified. These compounds exhibited improved cellular activities and maintained balance between p38a and CYP3A4 inhibition. |
| doi_str_mv | 10.1016/j.bmcl.2010.02.090 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_746228624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>746228624</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_7462286243</originalsourceid><addsrcrecordid>eNqNTbtOwzAU9QASLfADTHdjacyNa4WkWwRFLKCqZWCrnMaltzh2musO-fumFR_AdI7OU4iHFGWKafa0l1WzcVLhIKCSWOCVGGGRYZIX-vtGjJn3iKlGrUeCyoZqm1SGbQ3kd1RRDB1D2EI7zQ18lAv4JT_YEhami6Bm8GqZfvwEuPdxN3AG42tYlctLK0TrI3wmbd_RsN07MOcLvhPXW-PY3v_hrXh8m3-9vCdtFw5Hy3HdEG-sc8bbcOT1s86UyjOlp_9PngAZnk8u</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>746228624</pqid></control><display><type>article</type><title>Amide-based inhibitors of p38a MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides</title><source>Elsevier ScienceDirect Journals</source><creator>Tester, Richland ; Tan, Xuefei ; Luedtke, Gregory R ; Nashashibi, Imad ; Schinzel, Kurt ; Liang, Weiling ; Jung, Joon ; Dugar, Sundeep ; Liclican, Albert ; Tabora, Jocelyn ; Levy, Daniel E ; Do, Steven</creator><creatorcontrib>Tester, Richland ; Tan, Xuefei ; Luedtke, Gregory R ; Nashashibi, Imad ; Schinzel, Kurt ; Liang, Weiling ; Jung, Joon ; Dugar, Sundeep ; Liclican, Albert ; Tabora, Jocelyn ; Levy, Daniel E ; Do, Steven</creatorcontrib><description>Optimization of a tri-substituted N-pyridyl amide led to the discovery of a new class of potent N-pyrimidyl amide based p38a MAP kinase inhibitors. Initial SAR studies led to the identification of 5-dihydrofuran as an optimal hydrophobic group. Additional side chain modifications resulted in the introduction of hydrogen bond interactions. Through extensive SAR studies, analogs bearing free amino groups and alternatives to the parent (S)-a-methyl benzyl moiety were identified. These compounds exhibited improved cellular activities and maintained balance between p38a and CYP3A4 inhibition.</description><identifier>ISSN: 0960-894X</identifier><identifier>DOI: 10.1016/j.bmcl.2010.02.090</identifier><language>eng</language><ispartof>Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2560-2563</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Tester, Richland</creatorcontrib><creatorcontrib>Tan, Xuefei</creatorcontrib><creatorcontrib>Luedtke, Gregory R</creatorcontrib><creatorcontrib>Nashashibi, Imad</creatorcontrib><creatorcontrib>Schinzel, Kurt</creatorcontrib><creatorcontrib>Liang, Weiling</creatorcontrib><creatorcontrib>Jung, Joon</creatorcontrib><creatorcontrib>Dugar, Sundeep</creatorcontrib><creatorcontrib>Liclican, Albert</creatorcontrib><creatorcontrib>Tabora, Jocelyn</creatorcontrib><creatorcontrib>Levy, Daniel E</creatorcontrib><creatorcontrib>Do, Steven</creatorcontrib><title>Amide-based inhibitors of p38a MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides</title><title>Bioorganic & medicinal chemistry letters</title><description>Optimization of a tri-substituted N-pyridyl amide led to the discovery of a new class of potent N-pyrimidyl amide based p38a MAP kinase inhibitors. Initial SAR studies led to the identification of 5-dihydrofuran as an optimal hydrophobic group. Additional side chain modifications resulted in the introduction of hydrogen bond interactions. Through extensive SAR studies, analogs bearing free amino groups and alternatives to the parent (S)-a-methyl benzyl moiety were identified. These compounds exhibited improved cellular activities and maintained balance between p38a and CYP3A4 inhibition.</description><issn>0960-894X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNTbtOwzAU9QASLfADTHdjacyNa4WkWwRFLKCqZWCrnMaltzh2musO-fumFR_AdI7OU4iHFGWKafa0l1WzcVLhIKCSWOCVGGGRYZIX-vtGjJn3iKlGrUeCyoZqm1SGbQ3kd1RRDB1D2EI7zQ18lAv4JT_YEhami6Bm8GqZfvwEuPdxN3AG42tYlctLK0TrI3wmbd_RsN07MOcLvhPXW-PY3v_hrXh8m3-9vCdtFw5Hy3HdEG-sc8bbcOT1s86UyjOlp_9PngAZnk8u</recordid><startdate>20100415</startdate><enddate>20100415</enddate><creator>Tester, Richland</creator><creator>Tan, Xuefei</creator><creator>Luedtke, Gregory R</creator><creator>Nashashibi, Imad</creator><creator>Schinzel, Kurt</creator><creator>Liang, Weiling</creator><creator>Jung, Joon</creator><creator>Dugar, Sundeep</creator><creator>Liclican, Albert</creator><creator>Tabora, Jocelyn</creator><creator>Levy, Daniel E</creator><creator>Do, Steven</creator><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100415</creationdate><title>Amide-based inhibitors of p38a MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides</title><author>Tester, Richland ; Tan, Xuefei ; Luedtke, Gregory R ; Nashashibi, Imad ; Schinzel, Kurt ; Liang, Weiling ; Jung, Joon ; Dugar, Sundeep ; Liclican, Albert ; Tabora, Jocelyn ; Levy, Daniel E ; Do, Steven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_7462286243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tester, Richland</creatorcontrib><creatorcontrib>Tan, Xuefei</creatorcontrib><creatorcontrib>Luedtke, Gregory R</creatorcontrib><creatorcontrib>Nashashibi, Imad</creatorcontrib><creatorcontrib>Schinzel, Kurt</creatorcontrib><creatorcontrib>Liang, Weiling</creatorcontrib><creatorcontrib>Jung, Joon</creatorcontrib><creatorcontrib>Dugar, Sundeep</creatorcontrib><creatorcontrib>Liclican, Albert</creatorcontrib><creatorcontrib>Tabora, Jocelyn</creatorcontrib><creatorcontrib>Levy, Daniel E</creatorcontrib><creatorcontrib>Do, Steven</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tester, Richland</au><au>Tan, Xuefei</au><au>Luedtke, Gregory R</au><au>Nashashibi, Imad</au><au>Schinzel, Kurt</au><au>Liang, Weiling</au><au>Jung, Joon</au><au>Dugar, Sundeep</au><au>Liclican, Albert</au><au>Tabora, Jocelyn</au><au>Levy, Daniel E</au><au>Do, Steven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amide-based inhibitors of p38a MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><date>2010-04-15</date><risdate>2010</risdate><volume>20</volume><issue>8</issue><spage>2560</spage><epage>2563</epage><pages>2560-2563</pages><issn>0960-894X</issn><abstract>Optimization of a tri-substituted N-pyridyl amide led to the discovery of a new class of potent N-pyrimidyl amide based p38a MAP kinase inhibitors. Initial SAR studies led to the identification of 5-dihydrofuran as an optimal hydrophobic group. Additional side chain modifications resulted in the introduction of hydrogen bond interactions. Through extensive SAR studies, analogs bearing free amino groups and alternatives to the parent (S)-a-methyl benzyl moiety were identified. These compounds exhibited improved cellular activities and maintained balance between p38a and CYP3A4 inhibition.</abstract><doi>10.1016/j.bmcl.2010.02.090</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0960-894X |
| ispartof | Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2560-2563 |
| issn | 0960-894X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_746228624 |
| source | Elsevier ScienceDirect Journals |
| title | Amide-based inhibitors of p38a MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T07%3A44%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amide-based%20inhibitors%20of%20p38a%20MAP%20kinase.%20Part%202:%20Design,%20synthesis%20and%20SAR%20of%20potent%20N-pyrimidyl%20amides&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Tester,%20Richland&rft.date=2010-04-15&rft.volume=20&rft.issue=8&rft.spage=2560&rft.epage=2563&rft.pages=2560-2563&rft.issn=0960-894X&rft_id=info:doi/10.1016/j.bmcl.2010.02.090&rft_dat=%3Cproquest%3E746228624%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=746228624&rft_id=info:pmid/&rfr_iscdi=true |